BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 22610782)

  • 21. Haemodynamic and renal evolution of the bile duct-ligated rat.
    Martínez-Prieto C; Ortíz MC; Fortepiani LA; Ruiz-Maciá J; Atucha NM; García-Estañ J
    Clin Sci (Lond); 2000 May; 98(5):611-7. PubMed ID: 10781394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
    Huang HC; Wang SS; Lee JY; Chen YC; Lee FY; Lin HC; Chang CC; Lee SD
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1401-9. PubMed ID: 20659230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
    Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
    Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
    Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats.
    Verbeke L; Farre R; Trebicka J; Komuta M; Roskams T; Klein S; Elst IV; Windmolders P; Vanuytsel T; Nevens F; Laleman W
    Hepatology; 2014 Jun; 59(6):2286-98. PubMed ID: 24259407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of Salvia miltiorrhiza on cirrhotic rats.
    Huang YT; Lee TY; Lin HC; Chou TY; Yang YY; Hong CY
    Can J Physiol Pharmacol; 2001 Jul; 79(7):566-72. PubMed ID: 11478589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
    Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
    Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765.
    Gómez-Hurtado I; Zapater P; Portune K; Juanola O; Fernández-Iglesias A; González-Navajas JM; Gracia-Sancho J; Sanz Y; Francés R
    Eur J Nutr; 2019 Jun; 58(4):1647-1658. PubMed ID: 29748815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
    Chang FC; Huang YT; Lin HC; Hong CY; Lin JG; Chen KJ
    Can J Physiol Pharmacol; 1999 Aug; 77(8):618-24. PubMed ID: 10543725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
    J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
    Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats.
    Fan Q; Wu G; Chen M; Luo G; Wu Z; Huo H; Li H; Zheng L; Luo M
    Eur J Pharmacol; 2024 Feb; 964():176278. PubMed ID: 38158116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of nitric oxide synthase blockers on mesenteric blood flow with bile duct ligation.
    Yuksel BC; Tanriverdi P; Ozel H; Avsar FM; Topaloglu S; Iskit AB
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxix-ccxxi. PubMed ID: 15244184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
    Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.
    Theodorakis NG; Wang YN; Wu JM; Maluccio MA; Sitzmann JV; Skill NJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G792-9. PubMed ID: 19628654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability.
    Lee KC; Yang YY; Huang YT; Lee FY; Hou MC; Lin HC; Lee SD
    Clin Sci (Lond); 2010 Apr; 119(1):45-55. PubMed ID: 20132096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiloride reduces portal hypertension in rat liver cirrhosis.
    Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
    Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
    Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
    Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.